Article Text

THU0557 Reliability and Validity of Turkish Version of The fibromyalgia Rapid Screening Tool (First)
  1. R. Çeliker1,
  2. L. Altan2,
  3. A. Rezvani3,
  4. I. Aktaş4,
  5. N. Taştekin5,
  6. E. Dursun6,
  7. N. Dursun6,
  8. S. Sarıkaya7,
  9. S. Özdolap7,
  10. K. Akgün8,
  11. C. Zateri9,
  12. M. Birtane5
  1. 1Physical Medicine and Rehabilitation, Acibadem University, Faculty of Medicine, Istanbul
  2. 2Physical Medicine and Rehabilitation, Uludag University Medical faculty, Bursa
  3. 3Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Teaching and Research Hospital
  4. 4Physical Medicine and Rehabilitation, Bezmialem University, Faculty of Medicine, Istanbul
  5. 5Physical Medicine and Rehabilitation, Trakya University, Faculty of Medicine, Edirne
  6. 6Physical Medicine and Rehabilitation, Kocaeli University, Faculty of Medicine, Kocaeli
  7. 7Physical Medicine and Rehabilitation, Bulent Ecevit University, Faculty of Medicine, Zonguldak
  8. 8Physical Medicine and Rehabilitation, Istanbul University, Cerrahpaşa Faculty of Medicine, Istanbul
  9. 9Physical Medicine and Rehabilitation, Canakkale Onsekiz Mart University, Faculty of Medicine, Çanakkale, Turkey


Background Fibromyalgia is a challenging chronic pain condition accompanied by several comorbidites. Since patients are encountered in various health care settings, there is a need for short, easy to use, psychometrically validated screening tool

Objectives This study aims to evaluate reliability and validity of Turkish version of Fibromyalgia Rapid Screening Tool (FiRST) by correlating this tool with 2013 American College of Rheumatology alternative diagnostic criteria (ACR AltCr) and Hospital Anxiety and Depression Scale (HADS).

Methods A convenience sample of 269 subjects recruited from outpatient Physical Medicine and Rehabilitation clinics were included in the study. Patients were asked to complete the questionnaire including FiRST (twice), 2013 AltCr and HADS. The reliability of the FiRST scale was examined by test-retest method. For criterion validity of FiRST scale, we used ACR 2013AltCr for comparison. The concordance between ACRAltCr and FiRST and the relationships between variables were evaluated. The sensitivity, specificity, positive and negative likelihood ratios of FiRST was calculated according to ACR 2013 AltCr criteria. Logistic regression analysis was carried out to find the confounding effect of HADS on FiRST to discriminate the patients with FMS

Results The test-retest reliability coefficient of FiRST scale was r=0.875. FiRST was similar to ACR 2013 AltCr in defining patients with FMS. FiRST score was correlated with subscores of ACR 2013AltCr. Each point increase in FiRST global score increased odds of suffering FM approximately 10 times compared to HADS

Conclusions Turkish version of FiRST is a reliable instrument for identifying patients with FMS

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.